摘要
Introduction:
Ischemia core-associated microglia (ICAM) contribute to the pathological response following ischemic stroke. However, the transcriptional mechanisms underlying their disease-associated phenotypes remain poorly understood. This study aimed to identify key transcriptional regulators of ICAM and explore their therapeutic potential.
Methods:
A mouse transient middle cerebral artery occlusion (tMCAO) model was used to investigate the temporal expression of FOSL1 in microglia. Downstream transcriptional targets were identified and validated. The effects of microglia-targeted FOSL1 overexpression on microglial phenotypes and ischemic brain injury were evaluated. A small-molecule screening approach was further employed to identify potential FOSL1-targeting compounds.
Results:
FOSL1 expression was rapidly upregulated in microglia during the hyperacute phase after tMCAO, peaking at 12 h. Mechanistically, FOSL1 promoted the transcription of Fmn1, Lgals3, and Plau. Microglia-targeted FOSL1 overexpression enhanced pro-inflammatory, pro-chemotactic, and glycolytic phenotypes and exacerbated ischemic brain injury. Furthermore, we identified CP-02 as a candidate FOSL1-targeting compound, which effectively attenuated ischemic brain injury in vivo.
Conclusion:
FOSL1 acts as a key transcriptional regulator of pathological ICAM activation after ischemic stroke, promoting inflammatory, chemotactic, and glycolytic responses. Targeting FOSL1 with CP-02 may represent a promising therapeutic strategy for ischemic stroke.
